Delivering Advancements Through Action Imagine a metastatic (secondary) breast cancer community within the UK where everybody within it who has ever heard the words, ‘it’s incurable’, is counted and acknowledged
Kat wrote this blog for Metastatic May but we feel it should be shared again for Breast Cancer Awareness Month as data is a major problem and something that really
Clinical trials are one of those things that no one really cares about until you need to. In the UK we have a pretty impressive cancer trial landscape that’s recognised
Stage 4 shouldn’t be a label that says “treat differently” After living with Metastatic Breast Cancer for over 3 years, I am very familiar with the terms and definitions surrounding
Clinical trials are essential for testing new treatments for metastatic breast cancer (MBC). For patients, they represent hope – the chance to get access to a new potential treatment before
Having just completed screening for a clinical trial I must initiate this discussion. Trials offer treatments not otherwise available – so with limited treatments available, it’s without question that I
Accessing clinical trials is a minefield: firstly, you need to find a trial that you are eligible for, which can include factors such as your cancer sub-type, the receptors you
In our recent Metastatic May campaign, the theme was ‘The Cost of Living’. Living with metastatic breast cancer affects personal finances, careers, and overall income. But we also explored the
According to Cancer Research UK, approximately one in five of all new female breast cancer cases are under the age 50 and around half are between 35 – 64 (https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/breast-cancer/incidence-invasive).
Any patient with metastatic breast cancer (MBC) will be familiar with the concept of ‘treatment lines’. Unlike primary breast cancer, where you undergo chemotherapy for a fixed time period, after
